Nucala 100 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FFBM7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,182
Award facts
- Contract value 100% obligated
- $23,181.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $23,181.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nucala 100 mg/ml syringes. This firm fixed-price delivery order, awarded on November 24, 2025, with an ultimate completion date of November 25, 2025, was issued without a set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. The delivery will be performed in Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its primary operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy. The underlying IDC, designated SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, and positions the vendor as a critical pharmaceutical supplier for Department of Defense healthcare operations globally. The PPV-G GEN V contract structure includes a 30-month base period with three 30-month option periods extending through December 31, 2036, enabling DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical consumables to support military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FFBM7?
SPE2DR26FFBM7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FFBM7 worth?
The government has obligated $23,182 on SPE2DR26FFBM7.
Is contract SPE2DR26FFBM7 an order under another contract?
Yes. SPE2DR26FFBM7 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBM7 competed?
The extent of competition for SPE2DR26FFBM7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award